Miyashita, T <br/><br/>
Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2.  [electronic resource] 

 -  Transplantation proceedings  Nov 2000 
 - 2355-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(00)01697-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bioreactors<br/>Blood Pressure<br/>Cell Culture Techniques--methods<br/>Equipment Design<br/>Glutamate-Ammonia Ligase--genetics<br/>Heart Rate<br/>Hepatoblastoma<br/>Hepatocytes--cytology<br/>Humans<br/>Intracranial Pressure<br/>Ischemia<br/>Liver--blood supply<br/>Liver Failure--therapy<br/>Liver Neoplasms<br/>Liver, Artificial<br/>Recombinant Proteins--metabolism<br/>Swine<br/>Tumor Cells, Cultured